Here are relevant reports on : non-invasive-aesthetic-devices-market
-
Body Contouring Devices Market by Product (Non-invasive, Invasive), Application (Fat Reduction, Skin Tightening, Cellulite Treatment, Body Toning and Sculpting), Age Group (Below 35 Years, Between 35 to 50 Years, Above 50 Years) - Global Forecast to 2029
The global body contouring devices market, valued at US$1.59 billion in 2023, stood at US$1.74 billion in 2024 and is projected to advance at a resilient CAGR of 11.4% from 2024 to 2029, culminating in a forecasted valuation of US$3.00 billion by the end of the period. The growth of this market is primarily fueled by the rising prevalence of non invasive body contouring procedure, the perks of minimally invasive surgery compared to traditional body contouring surgeries, and the increasing awareness of the body contouring procedures.
- Published: October 2024
- Price: $ 4950
- TOC Available:
-
Anastomosis Devices Market by Product, Surgical Staplers (Manual, Powered), Surgical Sutures (Absorbable, Non-absorbable, Automated), and Surgical Sealants and Adhesives, Application (CVDs, GI Surgeries), End Users & Region - Global Forecast to 2027
The global anastomosis devices market in terms of revenue was estimated to be worth $3.0 billion in 2022 and is poised to reach $4.4 billion by 2027, growing at a CAGR of 8.3% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: August 2022
- Price: $ 4950
- TOC Available:
-
ASEAN Infusion Pump Market by Product (Accessories (Dedicated (Volumetric Pumps, Insulin Pumps, Enteral Pumps) & Non-dedicated), Devices (Traditional, Specialty)), Application (Oncology, Diabetes, Pain Management), End User - Global Forecast to 2030
The global ASEAN infusion pump market, valued at US$1.18 billion in 2024, stood at US$1.26 billion in 2025 and is projected to advance at a resilient CAGR of 7.1% from 2025 to 2030, culminating in a forecasted valuation of US$1.78 billion by the end of the period. The ASEAN infusion pump market is experiencing significant growth, driven by heightened healthcare awareness and enhanced access to sophisticated medical technologies throughout the region.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Infusion Pump Market by Product (Accessories (Dedicated, Non-dedicated), Devices (Insulin, Syringe, Volumetric, Enteral, PCA Pump)), Technology (Traditional, Specialty), Mode (Stationary, Portable), Application (Cancer, Diabetes) - Global Forecast to 2030
The global infusion pump market, valued at US$18.5 billion in 2024, stood at US$19.9 billion in 2025 and is projected to advance at a resilient CAGR of 7.4% from 2025 to 2030, culminating in a forecasted valuation of US$ 28.3 billion by the end of the period. The infusion pump market is expanding rapidly, driven by significant technological advancements in smart, interconnected, and automated systems that optimize the precision and safety of infusion therapy.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Medical Packaging Market by Material (Polymer, Non-woven Fabric, Paper & Paperboard), Packaging Type (Bags & Pouches, Trays, Boxes), Application (Medical Equipment & Tools, Medical Devices, Implants, IVDs), Packing Type, and Region - Forecast to 2022
The market for medical packaging is projected to grow from USD 35.31 Billion in 2016 to USD 50.55 Billion by 2022, at a compound annual growth rate (CAGR) of 6.29% from 2017 to 2022. The base year considered for the study is 2016 and the market size is projected from 2017 to 2022. The global market for medical packaging is dominated by large players such as Avery Dennison Corporation (U.S.), 3M Company (U.S.), E. I. du Pont de Nemours and Company (U.S.), CCL Industries, Inc. (Canada) , Amcor Limited (Australia), Constantia Flexibles Group GmbH (Austria), Bemis Company (U.S.) , Sonoco Products Company (U.S.) , WestRock Company (U.S.). These players have adopted various strategies to expand their global presence and increase their market share. Mergers & acquisitions, expansions, and new product launches are some of the major strategies adopted by market players to achieve growth in the medical packaging market.
- Published: July 2017
- Price: $ 4950
- TOC Available:
-
Europe Leukapheresis Market by Product (Devices, Disposable, Membrane Separators), Leukopak (Mobilized, Non-Mobilized), Indication (ALL, NHL, Multiple Myeloma), Application (Research, Therapeutic), End User (Hospitals, Pharma, Biotech) - Forecast to 2031
The Europe Leukapheresis market, valued at USD 22.6 million in 2025, stood at USD 24.2 million in 2026 and is projected to advance at a resilient CAGR of 7.1% from 2026 to 2031, culminating in a forecasted valuation of USD 34.1 million by the end of the period. This growth is due to the increasing number of applications for leukapheresis in cases pertaining to hematological disorders, coupled with an increase in the number of starting materials for cell & gene therapy applications.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
European Medical Devices Market by Type (Diagnostic Imaging, Endoscopy Equipment, Respiratory Care, Cardiac Monitoring Devices, Haemodialysis Devices, Ophthalmic Devices, Anesthesia Monitoring), End User (Hospitals, Home-care) & Region - Global Forecast to 2025
European medical devices market growth is primed to transition from $48.9 billion in 2020 to $61.4 billion by 2025, showcasing a strong CAGR of 4.7%. Key growth drivers include an aging population, advancements in medical technology, and an increasing number of surgical procedures, alongside the need for cost containment in healthcare.
- Published: May 2020
- Price: $ 4950
- TOC Available:
-
Dermatology Devices Market Size, Growth by Type (Diagnostic Devices (Dermatoscopes, Imaging Devices), Treatment Devices (Laser, Cryotherapy, Liposuction)), Application (Skin Cancer, Acne, Psoriasis, Skin Rejuvenation, Tattoo Removal) & Region - Global Forecast to 2027
The global dermatology devices market in terms of revenue was estimated to be worth $6.2 billion in 2022 and is poised to reach $11.3 billion by 2027, growing at a CAGR of 12.7% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: June 2022
- Price: $ 4950
- TOC Available:
-
Minimally Invasive Surgery Market by Type (Surgical Device, Imaging System, Electrosurgical Device, Endoscopy Device, Medical Robotics), Application (Urological, Vascular, Oncological), End User (Hospital, Clinic, ASC) Region-Global Forecast to 2030
The global minimally invasive surgery market, valued at US$81.65 billion in 2024, stood at US$94.45 billion in 2025 and is projected to advance at a resilient CAGR of 16.1% from 2025 to 2030, culminating in a forecasted valuation of US$199.30 billion by the end of the period.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Surgical Ablation Market by Technology (Radiofrequency, Light/Laser, Electrical, Cryoablation, Microwave, Ultrasound, Hydromechanical), Application (Open Surgery, Minimally Invasive, Cosmetic Surgery, Oncology, Cardiovascular, Orthopedic, Urology) - Global Forecast to 2019
The global surgical ablation market is poised to grow at a CAGR of 8.5% during 2014-2019, and is expected to reach a value of ~$1,567.0 Million in 2019. A number of factors such as growing geriatric population, coupled with an increasing population base of cancer and cardiovascular diseases, ongoing technological advancements in the field of ablation devices, growing awareness about benefits of ablation procedures over conventional therapeutic and surgical procedures, and rising number of hospitals and surgical centers are fuelling the growth of the global surgical ablation market. However, high cost-containment measures taken by various governments and ongoing healthcare reforms in the U.S. are some of the key factors hampering the market growth.
- Published: May 2026
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
